Abstract
This experiment investigated the possibility that rats maintained on chronic haloperidol treatment would show increased behavioral responsiveness to cocaine, similar to that observed in human stimulant abusers who are chronically treated with neuroleptics. Thus, the effects on locomotion and stereotyped behavior of intermittent injections of cocaine were investigated in female rats receiving chronic haloperidol treatment. Daily injections of haloperidol (0.2 mg/kg, IP) or vehicle were administered for 6, 12 or 18 days prior to the start of testing with cocaine and were then continued throughout cocaine testing. All rats received four doses of cocaine (0.0, 3.0, 7.5, or 15.0 mg/kg, IP) in random order with an intervening vehicle day between successive drug days. The four dose sequence of cocaine was repeated a total of four times. Initial cocaine administration produced dose dependent increases in locomotion and stereotyped behavior. When the sequence of cocaine doses was repeated, differences among treatment groups emerged. Groups treated with haloperidol exhibited heightened locomotion in response to cocaine and with repeated injections, showed a higher rate of behavioral sensitization than control animals. These differences in the behavioral response to cocaine were maintained for at least 2 months following termination of daily haloperidol treatment. In order to examine the mechanisms underlying this heightened responsiveness to cocaine, apomorphine-induced locomotion (dose range, 0–250 µg/kg, SC) was determined. Regardless of dose, rats treated with haloperidol showed different temporal patterns of locomotion in response to apomorphine suggesting that the increased response to cocaine was related to changes in dopaminergic receptor sensitivity.
Similar content being viewed by others
References
Bhattacharyya A, Aulakh C, Pradhan S, Ghosh P, Pradhan S (1979) Modification of behavioral and neurochemical effects of cocaine by haloperidol. Arch Int Pharmacodyn Ther 238:71–80
Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine in the striatum and nucleus accumbens in vivo. Neurosci Lett 78:199–204
Bunney BS (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. TINS 1:212–215
Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715–1728
Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571
Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killian KF (eds) Psychopharmacology: a generation in progress. Raven Press, New York, pp 1057–1070
Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619
Costall B, Naylor RJ (1975) The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system. Eur J Pharmacol 32:87–92
Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–436
Csernansky JG, Bellows EP, Barnes DE, Lombrozo L (1990) Sensitization to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmacology 101:519–524
Dewey KJ, Fibiger HC (1983) The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity. Naunyn-Schmiedeberg's Arch Pharmacol 322:261–270
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278
Di Chiara G, Porceddu ML, Vargiu L, Argiolas P, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in mouse brain. Nature 264:564–566
Dixon L, Hass G, Weiden P, Sweeney J, Frances A (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 148:224–230
Dustan R, Jackson DM (1976) The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 38:105–114
Ellinwood EH (1967) Amphetamine psychosis: I. description of individuals and process. J Nerv Ment Dis 144:273–283
Ellinwood EH, Kilbey MM (1977) Chronic stimulant intoxication models of psychosis. In: Hanin I, Usdin E (eds) Animal models in psychiatry and neurology. Pergamon Press, New York, pp 61–74
Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251:580–586
Groves PN, Rebec GV (1976) Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annu Rev Psychiatry 27:91–27
Halperin R, Guerin JJ, Davis KL (1983) Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat. Life Sci 33:585–592
Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 781–795
Ho BT, Taylor DL, Estevez VS (1977) Behavioral effects of cocainemetabolic and neurochemical approach. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Advances in behavioral biology, vol 21. Plenum Press, New York, pp 229–240
Imperato A, Gianluigi T, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257–264
Janowsky DS, Davis JM (1976) Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304–308
Kehr W, Carlsson A, Lindqvist M (1975) Biochemical aspects of dopamine agonists. In: Calne DB, Chase TN, Barbeau A (eds) Advances in neurology, vol 9. Raven Press, New York, pp 185–195
Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522
Kuczenski R, Segal D.S., Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712
Lane RF, Blaha CD (1987) Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain Res B 18:135–138
Lyon M, Robbins TW (1975) The action of central nervous system drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, vol 2. Spectrum, New York, pp 79–163
Maclennan A, Maier S (1983) Coping and the stress-induced potentiation of stimulant induced stereotypy in the rat. Science 219:1091–1093
Mesulam MM (1986) Cocaine and Tourette's syndrome. N Engl J Med 315:398
Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalance of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31–56
Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899–904
Post RM (1981) Central stimulants: clinical and experimental evidence on tolerance and sensitization. In: Israel Y, Glaser FB, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol 6. Plenum Press, New York, pp 1–65
Post RM, Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature 260:731–732
Prosser JG, Csernansky JG, Hollister LE (1988) Differences in the time course of haloperidol-induced up-regulation of rat striatial and mesolimbic dopamine receptors. Life Sci 43:715–720
Radhakishun FS, Van Ree JM (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur J Pharmacol 136:41–47
Randrup A, Munkvad I (1967) Stereotyped behavior produced by amphetamine in several animal species and man. Psychopharmacologia 11:300–310
Randrup A, Munkvad I, Udsen P (1963) Adrenergic mechanisms and amphetamine induced abnormal behavior. Actg Pharmacol Toxicol 20:145–157
Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD (1983) Behavioural and biochemical alterations following haloperidol treatment withdrawal: the animal model reexamined. Prog Neuropsychopharmacol 7:153–164
Rebec GV, Peirson EE, McPherson FA, Brugge K (1982) Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology 77:360–366
Richard ML, Liskow BI, Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. J Clin Psychiatry 46:79–83
Robbins TW, Mittleman G, O'Brien J, Winn P (1990) The neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper SJ, Dourish CT (eds) Neurobiology of stereotyped behavior. Clarendon Press, Oxford, pp 25–63
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res R 11:157–198
Rylander G (1971) Stereotyped behavior in man following amphetamine abuse. In: Baker SB (ed) The correlation of adverse effects in man with observations in animals. Excerpta Medica, Amsterdam, pp 29–31
Scheel-Kruger J, Braestrup C, Nielson M, Golembrowska K, Mogilnicka E (1977) Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Advances in behavioral biology, vol 21. Plenum Press, New York, pp 373–408
Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment Dis 175:641–652
Schnoll SH, Daghestani AN, Hansen TR (1984) Cocaine dependence. Resident Staff Physician 30:24–31
Seeger TF, Thal L, Gardner EL (1982) Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 76:182–187
Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249–255
Skirboll LR, Grace AA, Bunney BS (1979) Dopamine auto-and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80–82
Smith RC, Davis JM (1976) Behavioural evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine. Life Sci 19:725–732
Tarsy D, Baldessarini RJ (1974) Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with synaptic function of catecholamines. Neuropharmacology 13:927–940
Van Ree JM, Caffe AM, Wolterink G (1982) Non-opiate B-endorphin fragments and dopamine - III. y-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injections of apomorphine into the nucleus accumbens. Neuropharmacology 21:1103–1111
Westerink BHC, Horn AS (1979) Do neuroleptics prevent the penetration of dopamine agonists into the brain? Eur J Pharmacol 58:39–48
White FJ, Wang RY (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32:983–993
Wilmot CA, Szczepanik AM (1989) Effects of acute treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288–298
Winer BJ (1962) Statistical principles in experimental design. McGraw Hill, New York
Wise RA, Bozarth MA (1987) A psychmotor stimulant theory of addiction. Psychol Rev 94:469–492
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LeDuc, P.A., Mittleman, G. Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations. Psychopharmacology 110, 427–436 (1993). https://doi.org/10.1007/BF02244649
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244649